ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 147 filers reported holding ATARA BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $275,663 | -2.9% | 95,056 | +9.8% | 0.00% | – |
Q4 2022 | $283,953 | +22.4% | 86,571 | +40.7% | 0.00% | – |
Q3 2022 | $232,000 | -50.7% | 61,520 | +1.8% | 0.00% | – |
Q2 2022 | $471,000 | -21.8% | 60,434 | -6.7% | 0.00% | -100.0% |
Q1 2022 | $602,000 | -36.4% | 64,788 | +7.8% | 0.00% | 0.0% |
Q4 2021 | $946,000 | -93.9% | 60,102 | -93.0% | 0.00% | -87.5% |
Q3 2021 | $15,409,000 | -19.5% | 860,739 | -30.1% | 0.01% | -20.0% |
Q2 2021 | $19,139,000 | -46.9% | 1,230,794 | -50.9% | 0.01% | -44.4% |
Q1 2021 | $36,010,000 | +38.0% | 2,507,696 | +88.6% | 0.02% | +38.5% |
Q4 2020 | $26,098,000 | +47.8% | 1,329,488 | -2.4% | 0.01% | +18.2% |
Q3 2020 | $17,659,000 | -23.1% | 1,362,589 | -13.6% | 0.01% | -31.2% |
Q2 2020 | $22,969,000 | +5571.4% | 1,576,486 | +3211.2% | 0.02% | – |
Q1 2020 | $405,000 | -58.0% | 47,610 | -18.7% | 0.00% | -100.0% |
Q4 2019 | $964,000 | +108.7% | 58,559 | +78.9% | 0.00% | – |
Q3 2019 | $462,000 | -8.9% | 32,741 | +30.0% | 0.00% | – |
Q2 2019 | $507,000 | -50.4% | 25,194 | -2.0% | 0.00% | -100.0% |
Q1 2019 | $1,023,000 | +8.4% | 25,709 | -5.4% | 0.00% | 0.0% |
Q4 2018 | $944,000 | -0.2% | 27,184 | +18.9% | 0.00% | 0.0% |
Q3 2018 | $946,000 | -31.4% | 22,866 | -39.2% | 0.00% | 0.0% |
Q2 2018 | $1,380,000 | -13.4% | 37,592 | -8.0% | 0.00% | 0.0% |
Q1 2018 | $1,593,000 | +361.7% | 40,861 | +114.2% | 0.00% | – |
Q4 2017 | $345,000 | -18.4% | 19,072 | -25.4% | 0.00% | – |
Q3 2017 | $423,000 | +126.2% | 25,582 | +92.1% | 0.00% | – |
Q2 2017 | $187,000 | -68.4% | 13,319 | -53.7% | 0.00% | -100.0% |
Q1 2017 | $591,000 | +8.6% | 28,739 | -25.1% | 0.00% | 0.0% |
Q4 2016 | $544,000 | +21.7% | 38,350 | +83.2% | 0.00% | – |
Q3 2016 | $447,000 | -3.5% | 20,935 | +1.8% | 0.00% | -100.0% |
Q2 2016 | $463,000 | +81.6% | 20,566 | +53.6% | 0.00% | – |
Q1 2016 | $255,000 | -62.8% | 13,388 | -48.4% | 0.00% | -100.0% |
Q4 2015 | $685,000 | +112.1% | 25,930 | +152.2% | 0.00% | – |
Q3 2015 | $323,000 | -6.6% | 10,282 | +56.7% | 0.00% | – |
Q2 2015 | $346,000 | – | 6,560 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BRIDGER MANAGEMENT, LLC | 2,932,865 | $48,304,000 | 3.48% |
Camber Capital Management LP | 2,950,000 | $48,587,000 | 2.47% |
Trellus Management Company, LLC | 87,873 | $1,447,000 | 2.42% |
Redmile Group, LLC | 4,648,570 | $76,562,000 | 1.83% |
Baupost Group | 8,308,900 | $136,848,000 | 1.51% |
MAVERICK CAPITAL LTD | 4,958,431 | $81,665,000 | 1.19% |
Artal Group S.A. | 1,750,000 | $28,823,000 | 1.11% |
PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 175,000 | $2,882,000 | 0.36% |
12 West Capital Management LP | 158,700 | $2,614,000 | 0.16% |
WASATCH ADVISORS LP | 1,101,103 | $18,135,000 | 0.15% |